Table 2.
Antimicrobial susceptibility profiles of IMP-1-producing K. oxytoca from this study and a previous study [17].
| Strain Number | TK1604 | K27 |
|---|---|---|
| Year of isolation | 2018 | 2006 |
| MLST | ST88 | NT |
| Carbapenemase | IMP-1 | IMP-1 |
| ESBL | – | – |
| Cephalosporins | ||
| Cefazolin | >16 | >128 |
| Cefotaxim | >2 | 32 |
| Ceftazidime | >16 | >64 |
| Cefoperazone | NT | >128 |
| Sulbactam/cefoperazone | >32 | NT |
| Carbapenems | ||
| Imipenem | 4 | 2 |
| Meropenem | 8 | 4 |
| Monobactam | ||
| Aztreonam | 4 | 1 |
| Fluoroquinolones | ||
| Ciprofloxacin | 1 | 1 |
| Levofloxacin | 2 | 2 |
| Aminoglycosides | ||
| Gentamicin | 2 | 1 |
| Amikacin | 4 | 2 |
Minimum inhibitory concentration (MIC) values in bold indicate resistant; NT, not tested.